DDInter948 DDInter1547
Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD
A pyrazine that is used therapeutically as an antitubercular agent.
Pyrazinamide {u} (Compound) binds {v} (Gene) CYP1A2
Pyrazinamide {u} (Compound) downregulates {v} (Gene) PXDN
Pyrazinamide {u} (Compound) causes {v} (Side Effect) Gastrointestinal disorder
Pyrazinamide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Idelalisib
Pyrazinamide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Interferon beta-1a
Pyrazinamide {u} may lead to a major life threatening interaction when taken with {v} Teriflunomide
Pyrazinamide (Compound) binds CYP1A2 (Gene)
Pyrazinamide (Compound) downregulates PXDN (Gene)
Pyrazinamide (Compound) causes Gastrointestinal disorder (Side Effect)
Pyrazinamide may cause a moderate interaction that could exacerbate diseases when taken with Idelalisib
Pyrazinamide may cause a moderate interaction that could exacerbate diseases when taken with Interferon beta-1a
Pyrazinamide may lead to a major life threatening interaction when taken with Teriflunomide